Single Cause Single Cure
Single Cause Single Cure
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Single Cause Single Cure? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
Our mission is to cure cancer through metabolic therapies such as the ketogenic diet, hyperbaric oxygen, and re-purposed drugs. Our goal is to fund the research that may demonstrate the efficacy of these therapies so they may be incorporated into the oncology clinic for everyone.
About
During 2018, Single Cause Single Cure sponsored metabolic cancer research which resulted in the following written documents: (1) a research paper written by Dr. Thomas Seyfried on ketogenic metabolic therapy which was published in the Frontiers in Nutrition Journal; (2) a submitted paper on oxaloacetate experiments which is the abstract of Dr. Seyfried's don + kd-r study; and (3) an update on Dr. Seyfried's laboratories review to the Journal of Neurochemistry. Additionally, Dr. Seyfried's laboratory team found that the therapeutic effect of don + kd-r was significantly greater than the therapeutic effect of either the drug or diet therapy alone, which is indicative of significant synergy. Dr. Seyfried's lab is currently preparing a manuscript on don + kd-r for submission. Single Cause Single Cure continues to make progress researching cancer therapies that target cancer metabolically and can be implemented quickly.
Interesting data from their 2019 990 filing
The non-profit's aim, as indicated in the filing, is “See schedule o”.
When referring to its functions, they were specified as: “Our mission is to cure cancer through metabolic therapies such as the ketogenic diet, hyperbaric oxygen, and re-purposed drugs. our goal is to fund the research that may demonstrate the efficacy of these therapies so they may be incorporated into the oncology clinic for everyone.”.
- The non-profit has reported their operating state as SD, as required by law.
- As stated in the filing, the non-profit's address in 2019 was 3175 BLACK OAK PLACE, RAPID CITY, SD, 57702.
- The non-profit's form reports a total of 0 employees as of 2019.
- Does not operate a hospital.
- Does not operate a school.
- Does not collect art.
- Does not provide credit counseling.
- Does not have foreign activities.
- Is not a donor-advised fund.
- Is not a private foundation.
- Expenses are between $250,000 and $500,000.
- Revenue is between $100,000 and $250,000.
- Revenue less expenses is -$6,391.
- The remuneration of the CEO of the organization is not determined through an impartial review and approval process.
- The organization has 3 independent voting members.
- The organization was formed in 2013.
- The organization is required to file Schedule B.
- The organization is required to file Schedule O.
- The organization pays $0 in salary, compensation, and benefits to its employees.
- The organization pays $0 in fundraising expenses.
- The organization provides Form 990 to its governing body.
- The organization has minutes of its meetings.
- The organization has grants to organizations.